PROKR2

Prokineticin receptor 2 · Q8NFJ6 · PROKR2 on Sugi Atlas →

1,214 patent compounds predicted against PROKR2, 949 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL564621 SCHEMBL564621 0.81 5/20
SCHEMBL564897 SCHEMBL564897 0.78 5/20
SCHEMBL565368 SCHEMBL565368 0.78 5/20
SCHEMBL565832 SCHEMBL565832 0.78 5/20
SCHEMBL565393 SCHEMBL565393 0.78 5/20
SCHEMBL565726 SCHEMBL565726 0.78 5/20
SCHEMBL564405 SCHEMBL564405 0.78 5/20
SCHEMBL564196 SCHEMBL564196 0.77 5/20
SCHEMBL565095 SCHEMBL565095 0.77 5/20
SCHEMBL565605 SCHEMBL565605 0.77 5/20
SCHEMBL565513 SCHEMBL565513 0.76 5/20
SCHEMBL565351 SCHEMBL565351 0.76 5/20
SCHEMBL565632 SCHEMBL565632 0.76 5/20
SCHEMBL564281 SCHEMBL564281 0.76 5/20
SCHEMBL564206 SCHEMBL564206 0.75 5/20
SCHEMBL564802 SCHEMBL564802 0.75 5/20
SCHEMBL565012 SCHEMBL565012 0.75 5/20
SCHEMBL565706 SCHEMBL565706 0.75 5/20
SCHEMBL565721 SCHEMBL565721 0.75 5/20
SCHEMBL565844 SCHEMBL565844 0.75 5/20

Clinical trials — most relevant to PROKR2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes PHASE3UNKNOWN
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age PHASE3RECRUITING
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity PHASE3COMPLETED
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment PHASE1/PHASE2RECRUITING
Effects of Exenatide on Hypothalamic Obesity PHASE1/PHASE2COMPLETED
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans PHASE2NOT_YET_RECRUITING
The Role of Phosphodiesterase Inhibitors in Incretin Secretion PHASE1COMPLETED
Magnetic Resonance Imaging of Motility in Crohn's 1 nanCOMPLETED
Role of the Microbiota in Obesity: Effect After Bariatric Surgery nanCOMPLETED
Magnetic Resonance Imaging of Motility in Crohn's 2 nanCOMPLETED
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function nanCOMPLETED
Biological Sample Repository for Gastrointestinal Disorders nanACTIVE_NOT_RECRUITING
Nutritional Management of Acute and Chronic Enterocutaneous Fistulae nanUNKNOWN
Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in Children nanCOMPLETED
Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology nanCOMPLETED
Circular RNA and Chemerin in Breast Cancer Patient nanUNKNOWN
Dietary Carbohydrate and GERD in Veterans nanCOMPLETED
Facilitated Release of Endogenous Enterokines nanCOMPLETED
The Lean Living Study nanCOMPLETED
Pre- and Post-prandial Levels of Appetite Regulatory Hormones in Adults nanCOMPLETED
Endoscopic Gastric Reduction of Gastric Mucosa in Obesity nanUNKNOWN
Evaluation of Amino Acids Bioavailability in a Food Product Based on a Vegetable Protein Combination nanCOMPLETED
Renin and Prorenin in Pregnancy nanCOMPLETED
Eating Behaviour in Crohn's Disease nanCOMPLETED
Calorie Restriction in Multiple Sclerosis nanACTIVE_NOT_RECRUITING
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish) nanUNKNOWN
Brown Seaweed Extract on Glycemic Control and Body Weight nanCOMPLETED
Peanut Consumption on Cognitive, Weight, and Inflammation nanRECRUITING
Sequencing of 14 Genes From Leptin Melanocortin Pathway in Severe Obesity in Childhood. nanUNKNOWN
Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PROKR2 binder may also engage these)

ProteinNameSimilarity
Q8SPN1 1.000 Q8SPN1 →
Q8K458 1.000 Q8K458 →
Q8SPN2 1.000 Q8SPN2 →
PROKR1 Prokineticin receptor 1 1.000 landscape →
Q9JKL1 0.999 Q9JKL1 →
Q8R415 0.998 Q8R415 →
Q8R416 0.994 Q8R416 →
HCRTR2 Orexin receptor type 2 0.981 landscape →
Q5IS62 0.980 Q5IS62 →
Q9DDN6 0.980 Q9DDN6 →
O62809 0.980 O62809 →
Q9Z2D5 0.979 Q9Z2D5 →
Q9TUP7 0.978 Q9TUP7 →
Q9EQD2 0.978 Q9EQD2 →
Q924H0 0.978 Q924H0 →
O02836 0.978 O02836 →
P58308 0.976 P58308 →
NPY2R Neuropeptide Y receptor type 2 0.976 landscape →
Q6VZZ7 0.974 Q6VZZ7 →
Q9NYM4 0.973 Q9NYM4 →
P90745 0.973 P90745 →
Q8WPA2 0.973 Q8WPA2 →
P97295 0.973 P97295 →
Q9GK74 0.972 Q9GK74 →
P79945 0.971 P79945 →
P34311 0.971 P34311 →
BRS3 Bombesin receptor subtype-3 0.971 landscape →
P79113 0.971 P79113 →
Q9VNM1 0.970 Q9VNM1 →
Q9Y5Y3 0.970 Q9Y5Y3 →